Damora Therapeutics, Inc.
DMRABiotechnology
$22.01+1.85%As of Oct 29vs prior close
- Market cap
- $1.4B
- P/E (TTM)
- –
- From 52W high
- −35.53%
- EPS (LTM)
- $7.49
Nomior Score
51
Steady ProfileSpeculativeTop 47% of the scored universe
Growth40
Quality44
Value—
Momentum84
Resilience40